Saturday, July 5, 2025

Latest:

Surviving cancer and tracheoesophageal fistula: Sandy Tovey’s journey
Handy ‘MasSpec Pen’ collection could help detect opioids from the skin
A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

patent

From The Labs

From the labs to patent; osteoarthritis gene-therapy product is moving toward clinical trials

June 18, 2019 clinical trial, gene therapy, Il-1, Osteoarthritis, patent, Research

More than 30 million people in the United States alone are affected by osteoarthritis (OA), a degenerative joint disease, and that number is expected to

Policywise

Licensing ‘CRISPR’ patents to promote public interests

January 18, 2017 Center for Medical Ethics and Health Policy, Christi Guerrini, CRISPR, patent

Designer babies. Super soldiers. Unstable ecosystems. These are just a few of the feared outcomes from uncontrolled application of the new gene-editing technology known as

From the Labs: a closer look at metastatic medulloblastoma